Literature DB >> 26473792

Moyamoya angiopathy - Is there a Western phenotype?

Pennylouise Hever1, Alexander Alamri2, Christos Tolias2.   

Abstract

Moyamoya disease (MMD) is a chronic cerebrovascular disease involving progressive bilateral stenosis of the intracranial segments of the internal carotid arteries. It results in the development of a rich, but friable collateral supply, prone to rupture. The disease is well described in Japanese literature and was originally thought to be a predozminantly Eastern disease. However, the recent literature describes a Western phenotype that may present with a different clinical course. This review aims to describe the variations in the epidemiology of the MMD between Eastern and Western populations, the possible reasons for them and highlight their implications for clinical practise and future research.

Entities:  

Keywords:  Epidemiology; moyamoya disease; moyamoya syndrome; phenotype

Mesh:

Year:  2015        PMID: 26473792     DOI: 10.3109/02688697.2015.1096902

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  9 in total

1.  Moyamoya disease and moyamoya syndrome in Ireland: patient demographics, mode of presentation and outcomes of EC-IC bypass surgery.

Authors:  Ronan J Doherty; John Caird; Darach Crimmins; Peter Kelly; Sean Murphy; Christopher McGuigan; Niall Tubridy; Mary D King; Bryan Lynch; David Webb; Desmond O'Neill; Dominick J H McCabe; Peter Boers; Mary O'Regan; Joan Moroney; David J Williams; Simon Cronin; Mohsen Javadpour
Journal:  Ir J Med Sci       Date:  2020-06-19       Impact factor: 1.568

2.  Microembolic signals and antiplatelet therapy in Moyamoya angiopathy.

Authors:  Rolf R Diehl; Markus Kraemer; Mosche Pompsch; Roland Veltkamp
Journal:  J Neurol       Date:  2022-08-24       Impact factor: 6.682

3.  Patients with Moyamoya Vasculopathy Evaluated at a Single-Center in The Netherlands; Clinical Presentation and Outcome.

Authors:  Annick Kronenburg; Rachel Kleinloog; Albert van der Zwan; L Jaap Kappelle; Luca Regli; Kees P J Braun; Catharina J M Klijn
Journal:  J Clin Med       Date:  2021-04-27       Impact factor: 4.241

4.  Moyamoya Disease May Mimic Multiple Sclerosis?

Authors:  Ioanna Spanou; Maria-Eleftheria Evangelopoulos; Georgios Velonakis; Nikolaos Logiotatos; Achilleas Chatziioannou; Constantinos Potagas; Constantinos Kilidireas; Sophia Vassilopoulou
Journal:  Case Rep Neurol Med       Date:  2019-05-02

5.  Moyamoya vasculopathy in a young Caucasian woman with significant methamphetamine use.

Authors:  Tiffany Lin; Charmaine Yam; Su-Ling Lai; Geoffrey Cloud
Journal:  BMJ Neurol Open       Date:  2020-05-28

6.  Epidemiology of Moyamoya Angiopathy in Eastern India.

Authors:  Shambaditya Das; Souvik Dubey; Suman Das; Avijit Hazra; Alak Pandit; Ritwik Ghosh; Biman Kanti Ray
Journal:  Front Neurol       Date:  2022-03-04       Impact factor: 4.003

7.  Whole Exome Sequencing in a Series of Patients with a Clinical Diagnosis of Tuberous Sclerosis Not Confirmed by Targeted TSC1/TSC2 Sequencing.

Authors:  Erzsebet Kovesdi; Reka Ripszam; Etelka Postyeni; Emese Beatrix Horvath; Anna Kelemen; Beata Fabos; Viktor Farkas; Kinga Hadzsiev; Katalin Sumegi; Lili Magyari; Pilar Guatibonza Moreno; Peter Bauer; Bela Melegh
Journal:  Genes (Basel)       Date:  2021-09-10       Impact factor: 4.096

Review 8.  The Genetic Basis of Moyamoya Disease.

Authors:  R Mertens; M Graupera; H Gerhardt; A Bersano; E Tournier-Lasserve; M A Mensah; S Mundlos; P Vajkoczy
Journal:  Transl Stroke Res       Date:  2021-09-16       Impact factor: 6.829

9.  The angiographic presentation of European Moyamoya angiopathy.

Authors:  Sara Pilgram-Pastor; René Chapot; Markus Kraemer
Journal:  J Neurol       Date:  2021-07-08       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.